CS MEDICA receives 2 MDKK to support its short-term financial obligations.

REG

LHX Invest has concluded an agreement with ProArk, securing funding of 2 MDKK to CS MEDICA. The Agreement is based on the following terms;

  • As collateral for the funding, LHX Invest, owned by Lone Henriksen, CEO of CS MEDICA has transferred 1,333,333 common shares of CS MEDICA to ProArk.
  • CS MEDICA must within 8 months, pay ProArk 4 MDKK, (giving an effective interest rate of 100%) to get the shares back, ensuring the shares in full are returned to LHX Invest. If payments are not secured the shares will fall to ProArk.

Gitte Lund Henriksen, CFO of CS MEDICA, stated, "While this is an expensive solution, it reinforces our commitment to achieving our strategic objectives and allows us to avoid dilution of our shares. This injection of 2 million DKK is crucial for supporting our immediate financial needs."

Datum 2024-05-28, kl 17:14
Källa Cision
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet